Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Launching the Neuroendocrine Life Alliance

Launching the Neuroendocrine Life Alliance

Neuroendocrine Cancer UK and the Association for Multiple Endocrine Neoplasia Disorders (AMEND) are proud to announce the launch of the Neuroendocrine Life Alliance. This exciting new collaboration between Neuroendocrine Cancer UK and the Association for Multiple...

read more
The First-Ever World Hormone Day – Today, 24th April 2025

The First-Ever World Hormone Day – Today, 24th April 2025

24 April 2025 – The first World Hormone Day takes place today to raise awareness of the vital role of hormones in rare and chronic disease. Under the banner of #BecauseHormonesMatter, the campaign brings together the global endocrine community to share the small steps...

read more